"Commentary: The safety and efficacy of balloon-expandable vs. self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis" by Michael J Reardon

Selected Works of Tanvir K. Bajwa MD, FACC, FSCAI

Article

Commentary: The safety and efficacy of balloon-expandable vs. self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis

Frontiers in cardiovascular medicine

Michael J Reardon, Houston Methodist-DeBakey Heart and Vascular Center, Houston, TX, United States.
Tanvir Bajwa, Advocate Aurora Health
Jeffrey J Popma, Medtronic, Minneapolis, MN, United States.

Link

Affiliations

Aurora St. Luke's Medical Center

Scholarly Activity Date

12-18-2023

Type

Response or Comment

PubMed ID

38193022

Citation Information

Reardon MJ, Bajwa T, Popma JJ. Commentary: The safety and efficacy of balloon-expandable vs. self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis. Front Cardiovasc Med. 2023;10:1295274. Published 2023 Dec 18. doi:10.3389/fcvm.2023.1295274